Modern pharmaceutical delivery systems are intended to produce plasma
drug concentration versus time profiles that result in optimum therape
utic efficacy and a minimum of drug concentration-dependent adverse ef
fects. To accomplish this requires that the drug delivery rate and tem
poral profile be based on the pharmacokinetic and pharmacodynamic char
acteristics of the specific medicinal agent. Pharmacokinetic and pharm
acodynamic parameters are subject to considerable interindividual vari
ability. Whereas the importance of pharmacokinetic variability is gene
rally recognized, the significance of pharmacodynamic variability (i.e
., variability in the relationship between effect intensity and drug c
oncentration) is not as widely appreciated. Pharmacodynamic variabilit
y is typically quite large, reproducible, and often substantially exce
eds the relative magnitude of pharmacokinetic variability. This articl
e consists of a review of how to assess pharmacodynamic variability, c
linical examples of pharmacodynamic variability of drugs with a wide r
ange of indications, and an outline of mechanisms of pharmacodynamic v
ariability. (C) 1998 Elsevier Science B.V. All rights reserved.